|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Forner A, Reig M and Bruix J:
Hepatocellular carcinoma. Lancet. 391:1301–1314. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chan AWH, Zhong J, Berhane S, Toyoda H,
Cucchetti A, Shi K, Tada T, Chong CCN, Xiang BD, Li LQ, et al:
Development of pre and post-operative models to predict early
recurrence of hepatocellular carcinoma after surgical resection. J
Hepatol. 69:1284–1293. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Giordano S and Columbano A: MicroRNAs: New
tools for diagnosis, prognosis, and therapy in hepatocellular
carcinoma? Hepatology. 57:840–847. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang L, Mo H, Jiang Y, Wang Y, Sun L, Yao
B, Chen T, Liu R, Li Q, Liu Q and Yin G: MicroRNA-519c-3p promotes
tumor growth and metastasis of hepatocellular carcinoma by
targeting BTG3. Biomed Pharmacother. 118:1092672019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu Q, Zhu Q, Zhou Z, Wang Y, Liu X, Yin G,
Tong X and Tu K: MicroRNA-876-5p inhibits epithelial-mesenchymal
transition and metastasis of hepatocellular carcinoma by targeting
BCL6 corepressor like 1. Biomed Pharmacother. 103:645–652. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Yang Z, Wang L, Sun L, Liu Z, Li
Q, Yao B, Chen T, Wang C, Yang W, et al: MiR-532-3p promotes
hepatocellular carcinoma progression by targeting PTPRT. Biomed
Pharmacother. 109:991–999. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu Z, Wang Y, Dou C, Sun L, Li Q, Wang L,
Xu Q, Yang W, Liu Q and Tu K: MicroRNA-1468 promotes tumor
progression by activating PPAR-ү-mediated AKT signaling in human
hepatocellular carcinoma. J Exp Clin Cancer Res. 37:492018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yao B, Li Y, Wang L, Chen T, Niu Y, Liu Q
and Liu Z: MicroRNA-3194-3p inhibits metastasis and
epithelial-mesenchymal transition of hepatocellular carcinoma by
decreasing Wnt/β-catenin signaling through targeting BCL9. Artif
Cells Nanomed Biotechnol. 47:3885–3895. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang T, Cai X, Li Q, Xue P, Chen Z, Dong
X and Xue Y: Hsa-miR-875-5p exerts tumor suppressor function
through down-regulation of EGFR in colorectal carcinoma (CRC).
Oncotarget. 7:42225–42240. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
El Bezawy R, Cominetti D, Fenderico N,
Zuco V, Beretta GL, Dugo M, Arrighetti N, Stucchi C, Rancati T,
Valdagni R, et al: MiR-875-5p counteracts epithelial-to-mesenchymal
transition and enhances radiation response in prostate cancer
through repression of the EGFR-ZEB1 axis. Cancer Lett. 395:53–62.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang J, Lu Y, Ding H, Gu T, Gong C, Sun J,
Zhang Z, Zhao Y and Ma C: The miR-875-5p inhibits SATB2 to promote
the invasion of lung cancer cells. Gene. 644:13–19. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yin JY, Shen J, Dong ZZ, Huang Q, Zhong
MZ, Feng DY, Zhou HH, Zhang JT and Liu ZQ: Effect of eIF3a on
response of lung cancer patients to platinum-based chemotherapy by
regulating DNA repair. Clin Cancer Res. 17:4600–4609. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dong Z and Zhang JT: Initiation factor
eIF3 and regulation of mRNA translation, cell growth, and cancer.
Crit Rev Oncol Hematol. 59:169–180. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yin JY, Zhang JT, Zhang W, Zhou HH and Liu
ZQ: eIF3a: A new anticancer drug target in the eIF family. Cancer
Lett. 412:81–87. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fang C, Chen YX, Wu NY, Yin JY, Li XP,
Huang HS, Zhang W, Zhou HH and Liu ZQ: MiR-488 inhibits
proliferation and cisplatin sensibility in non-small-cell lung
cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling
pathway. Sci Rep. 7:403842017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang SQ, Liu Y, Yao MY and Jin J:
Eukaryotic translation initiation factor 3a (eIF3a) promotes cell
proliferation and motility in pancreatic cancer. J Korean Med Sci.
31:1586–1594. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ding Z, Liu J, Wang J, Huang B and Zhong
M: Upregulation of eukaryotic translation initiation factor 3
subunit a promotes cell survival in ameloblastoma. Oral Surg Oral
Med Oral Pathol Oral Radiol. 128:146–153. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Miao B, Wei C, Qiao Z, Han W, Chai X, Lu
J, Gao C, Dong R, Gao D, Huang C, et al: eIF3a mediates
HIF1α-dependent glycolytic metabolism in hepatocellular carcinoma
cells through translational regulation. Am J Cancer Res.
9:1079–1090. 2019.PubMed/NCBI
|
|
23
|
Liu Z, Dou C, Jia Y, Li Q, Zheng X, Yao Y,
Liu Q and Song T: RIG-I suppresses the migration and invasion of
hepatocellular carcinoma cells by regulating MMP9. Int J Oncol.
46:1710–1720. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jansson MD and Lund AH: MicroRNA and
cancer. Mol Oncol. 6:590–610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dou C, Zhou Z, Xu Q, Liu Z, Zeng Y, Wang
Y, Li Q, Wang L, Yang W, Liu Q and Tu K: Hypoxia-induced TUFT1
promotes the growth and metastasis of hepatocellular carcinoma by
activating the Ca2+/PI3K/AKT pathway. Oncogene.
38:1239–1255. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu Z, Wang Y, Dou C, Xu M, Sun L, Wang L,
Yao B, Li Q, Yang W, Tu K and Liu Q: Hypoxia-induced up-regulation
of VASP promotes invasiveness and metastasis of hepatocellular
carcinoma. Theranostics. 8:4649–4663. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu Q, Liu X, Liu Z, Zhou Z, Wang Y, Tu J,
Li L, Bao H, Yang L and Tu K: MicroRNA-1296 inhibits metastasis and
epithelial-mesenchymal transition of hepatocellular carcinoma by
targeting SRPK1-mediated PI3K/AKT pathway. Mol Cancer. 16:1032017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dou C, Liu Z, Xu M, Jia Y, Wang Y, Li Q,
Yang W, Zheng X, Tu K and Liu Q: MiR-187-3p inhibits the metastasis
and epithelial-mesenchymal transition of hepatocellular carcinoma
by targeting S100A4. Cancer Lett. 381:380–390. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu Z, Wang Y, Wang L, Yao B, Sun L, Liu
R, Chen T, Niu Y, Tu K and Liu Q: Long non-coding RNA AGAP2-AS1,
functioning as a competitive endogenous RNA, upregulates ANXA11
expression by sponging miR-16-5p and promotes proliferation and
metastasis in hepatocellular carcinoma. J Exp Clin Cancer Res.
38:1942019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dong Z and Zhang JT: EIF3 p170, a mediator
of mimosine effect on protein synthesis and cell cycle progression.
Mol Biol Cell. 14:3942–3951. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu TR, Lu RF, Romano D, Pitt A, Houslay
MD, Milligan G and Kolch W: Eukaryotic translation initiation
factor 3, subunit a, regulates the extracellular signal-regulated
kinase pathway. Mol Cell Biol. 32:88–95. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dong Z, Liu LH, Han B, Pincheira R and
Zhang JT: Role of eIF3 p170 in controlling synthesis of
ribonucleotide reductase M2 and cell growth. Oncogene.
23:3790–3801. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu RY, Dong Z, Liu J, Yin JY, Zhou L, Wu
X, Yang Y, Mo W, Huang W, Khoo SK, et al: Role of eIF3a in
regulating cisplatin sensitivity and in translational control of
nucleotide excision repair of nasopharyngeal carcinoma. Oncogene.
30:4814–4823. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Y, Yu JJ, Tian Y, Li ZZ, Zhang CY,
Zhang SF, Cao LQ, Zhang Y, Qian CY, Zhang W, et al: eIF3a improve
cisplatin sensitivity in ovarian cancer by regulating XPC and
p27Kip1 translation. Oncotarget. 6:25441–25451. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Spilka R, Ernst C, Bergler H, Rainer J,
Flechsig S, Vogetseder A, Lederer E, Benesch M, Brunner A, Geley S,
et al: eIF3a is over-expressed in urinary bladder cancer and
influences its phenotype independent of translation initiation.
Cell Oncol (Dordr). 37:253–267. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Heo CK, Hwang HM, Lee HJ, Kwak SS, Yoo JS,
Yu DY, Lim KJ, Lee S and Cho EW: Serum anti-EIF3A autoantibody as a
potential diagnostic marker for hepatocellular carcinoma. Sci Rep.
9:110592019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fattovich G, Stroffolini T, Zagni I and
Donato F: Hepatocellular carcinoma in cirrhosis: Incidence and risk
factors. Gastroenterology. 127 (5 Suppl 1):S35–S50. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
He P, Yu ZJ, Sun CY, Jiao SJ and Jiang HQ:
Knockdown of eIF3a attenuates the pro-fibrogenic response of
hepatic stellate cells induced by TGF-β1. Cell Mol Biol
(Noisy-le-grand). 62:107–111. 2016.PubMed/NCBI
|
|
40
|
Zhang YF, Wang Q, Luo J, Yang S, Wang JL
and Li HY: Knockdown of elF3a inhibits collagen synthesis in renal
fibroblasts via Inhibition of transforming growth factor-β1/Smad
signaling pathway. Int J Clin Exp Pathol. 8:8983–8989.
2015.PubMed/NCBI
|
|
41
|
Li T and Zhao J: Knockdown of elF3a
inhibits TGF-β1-induced extracellular matrix protein expression in
keloid fibroblasts. Mol Med Rep. 17:4057–4061. 2018.PubMed/NCBI
|
|
42
|
Li XW, Wu YH, Li XH, Li D, Du J, Hu CP and
Li YJ: Role of eukaryotic translation initiation factor 3a in
bleomycin-induced pulmonary fibrosis. Eur J Pharmacol. 749:89–97.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li WQ, Li XH, Wu YH, Du J, Wang AP, Li D
and Li YJ: Role of eukaryotic translation initiation factors 3a in
hypoxia-induced right ventricular remodeling of rats. Life Sci.
144:61–68. 2016. View Article : Google Scholar : PubMed/NCBI
|
